The purpose of this study is (1) to determine whether a 12-month trial of patients from
underserved communities with clinically significant gum disease and kidney disease randomly
assigned to intensive gum disease treatment or delayed treatment is feasible and (2) to
determine the variability of various tests of kidney function and inflammation in response to
intensive gum disease treatment.